DRUG

sapanisertib

3 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for sapanisertib

Epilepsy 2

Mediator Outcome Score Tier Lit. status Trial
mTOR neuronal spiking activity 0.208 Mid novel signal none
mTOR mTOR-opathies 0.208 Mid novel signal none

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
mTOR pancreatic ductal adenocarcinoma 0.208 Mid partial evidence none

Clinical trials

50 registered trials for sapanisertib

Source: ClinicalTrials.gov